期刊文献+

利培酮与舒必利对精神分裂症患者血脂代谢的影响 被引量:3

The side-effects of Risperidone and Sulpiride on the lipid metabolism in the schizophrenic patients
下载PDF
导出
摘要 目的:探讨利培酮和舒必利对首发精神分裂症患者血脂代谢的影响。方法:对2008年1月~2010年1月我院住院的精神分裂症患者547例测定利培酮和舒必利治疗8周前后的血胆固醇(TC)及三酰甘油(TG)浓度。结果:①利培酮治疗后,血胆固醇及血三酰甘油明显升高(t=2.94,P=0.003;t=2.56,P=0.011),且男性患者组升高较女性明显(t=2.47,P=0.015;t=2.29,P=0.023);②舒必利组治疗后血胆固醇及血三酰甘油明显升高(t=2.35,P=0.019;t=2.16,P=0.032),且女性TG升高的程度显著大于男性患者(t=3.11,P=0.002)。③利培酮对于血胆固醇及三酰甘油的影响大于舒必利(t=3.24,P=0.001;t=2.27,P=0.021)。结论:利培酮使血胆固醇及三酰甘油水平升高,对男性影响大。舒必利使血胆固醇及三酰甘油水平升高,对女性影响大。利培酮对TC的影响大于舒必利。 Objective:To explore the side-effects of Risperidone and Sulpiride on the lipid metabolism in schizophrenic patients.Methods:547 schizophrenic inpatients were recruited from January 2008 to January 2010.The concentrations of TC and TG after 8 week Risperidone or Sulpiride treatment were detected.Results:①After Risperidone treatment,TC and TG concentrations were significantly increased(t=2.94,P=0.003;t=2.56,P=0.011).Moreover,male patients had the more severe side-effects on the lipid metabolism than female(t=2.47,P=0.015;t=2.29,P=0.023).②After Sulpiride treatment,TC and TG concentrations were significantly increased(t=2.35,P=0.019;t=2.16,P=0.032).Moreover,TG concentrations of female patients increased more highly than those of male(t=3.11,P=0.002).③Risperidone had the more effects on TC and TG than Sulpiride(t=3.24,P=0.001;t=2.27,P=0.021).Conclusion:Risperidone could raise the TC and TG concentrations,and more greatly in male patients.Sulpiride raises the TC and TG concentrations,and more greatly in female patients.Risperidone has the more effects on TC and TG than Sulpiride.
出处 《中国医药导报》 CAS 2011年第19期15-17,共3页 China Medical Herald
基金 国家自然科学基金(81000581) 上海市科学技术委员会科研计划项目(10ZR1425700)
关键词 利培酮 舒必利 精神分裂症 血脂 Risperidone Sulpiride Schizophrenia Blood lipid
  • 相关文献

参考文献16

二级参考文献31

共引文献128

同被引文献24

  • 1吴仁容,赵靖平.四种抗精神病药对糖代谢及脂代谢的不良影响[J].中华精神科杂志,2005,38(3):130-133. 被引量:83
  • 2曹青.利培酮与舒必利治疗慢性精神分裂的对照研究[J].中华临床医学杂志,2005,6(11):32-33. 被引量:1
  • 3陈修哲,杨晓华,陈建平,高蕊,杨晓东,郝维德.抗精神病药物对精神分裂症患者血脂、血糖和体重影响的研究[J].山东精神医学,2006,19(1):11-13. 被引量:19
  • 4Kim E, Gupta S, Bolge S, et al. Adherence and outcomes associ- ated with copayment burden in schizophrenia: a cross-sectional sur- vey[J]. J MedEcon, 2010,13(2) :185-192.
  • 5Goodwin GM, Anderson I, Arango C, et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007 [ J]. Eur Neuro- psychopha:rnacol, 2008,18 ( 7 ) :535-549.
  • 6Tandon R. Antipsychotics in the treatment of schizophrenia: an o- verview [ J ]. J Clin Psychiatry, 2011,72 ( Suppl 1 ) :4-8.
  • 7Tandon R, Belmaker RH, Gattaz WF, et al. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia [ J]. Schizophr Res, 2008,100( 1-3 ) :20-38.
  • 8Melkersson KI, Dahl ML, Huhing AL. Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose- insulin homeostasis and lipid metabolism[ J]. Psyehopharmaeology (Brel) , 2004,175 ( 1 ) : 1-6.
  • 9Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabo- lism in patients with schizophrenia treated with atypical antipsy- ehotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis[ J]. Arch Gen Psychiatry. 2005, 62(1) :19-28.
  • 10Minet-Ringuet J, Even PC, Valet P, et al. Aherations of lipid me- tabolism and gene expression in rat adipocytes during chronic olanzapine treatment[ J]. Mol psychiatry, 2007,12(6) :562-571.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部